Divi's Laboratories Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Divi's Laboratories de 23.9% y 13.5% por año respectivamente. Se prevé que el BPA crezca en un 21.6% al año. Se espera que la rentabilidad financiera sea de 16% en 3 años.

Información clave

23.9%

Tasa de crecimiento de los beneficios

21.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Life Sciences	25.2%
Tasa de crecimiento de los ingresos	13.5%
Rentabilidad financiera futura	16.0%
Cobertura de analistas	Good
Última actualización	19 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Apr 19

Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 21

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Jul 07

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Jul 03

Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Apr 03

Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?

Dec 23

With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting

Sep 02

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Is Well Worth Watching

Mar 25

Do Institutions Own Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Mar 10

Who Has Been Selling Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Feb 23

Is Divi's Laboratories' (NSE:DIVISLAB) Share Price Gain Of 216% Well Earned?

Jan 25

Is Divi's Laboratories Limited's(NSE:DIVISLAB) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jan 07

Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Dec 20

What Type Of Shareholders Own The Most Number of Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Dec 03

Previsiones de crecimiento de beneficios e ingresos

NSEI:DIVISLAB - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	114,865	27,470	16,548	N/A	2
3/31/2026	102,505	25,170	12,500	N/A	21
3/31/2025	88,633	20,396	7,694	N/A	23
3/31/2024	76,786	15,416	8,985	N/A	23
12/31/2023	74,926	13,834	N/A	N/A	N/A
9/30/2023	73,456	13,314	7,927	15,127	N/A
6/30/2023	72,906	14,774	N/A	N/A	N/A
3/31/2023	77,676	18,234	19,867	24,597	N/A
12/31/2022	83,353	23,971	N/A	N/A	N/A
9/30/2022	91,208	29,925	22,153	28,404	N/A
6/30/2022	92,538	31,054	N/A	N/A	N/A
3/31/2022	89,599	29,605	11,986	19,118	N/A
12/31/2021	82,297	25,678	N/A	N/A	N/A
9/30/2021	74,379	21,362	4,760	13,465	N/A
6/30/2021	71,996	20,493	N/A	N/A	N/A
3/31/2021	69,695	19,843	10,367	19,469	N/A
12/31/2020	65,710	18,705	N/A	N/A	N/A
9/30/2020	62,658	17,590	10,714	20,167	N/A
6/30/2020	59,620	15,962	N/A	N/A	N/A
3/31/2020	53,945	13,765	327	12,159	N/A
12/31/2019	52,719	12,803	N/A	N/A	N/A
9/30/2019	52,356	13,106	-3,430	7,962	N/A
6/30/2019	51,139	13,575	N/A	N/A	N/A
3/31/2019	49,463	13,527	2,212	9,543	N/A
3/31/2018	38,915	8,770	5,020	7,759	N/A
3/31/2017	40,643	10,604	N/A	11,504	N/A
3/31/2016	37,764	11,258	N/A	10,379	N/A
3/31/2015	31,049	8,515	N/A	8,263	N/A
3/31/2014	25,267	7,733	N/A	5,567	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (23.9% al año) de DIVISLAB es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (23.9% al año) de DIVISLAB crezcan más rápidamente que el mercado Indian (17.8% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de DIVISLAB crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (13.5% al año) de DIVISLAB crezcan más rápidamente que los del mercado Indian (10.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 13.5% al año) de DIVISLAB crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de DIVISLAB sea baja dentro de 3 años (16%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Divi's Laboratories Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates fall by 10%

Price target increased by 7.3% to ₹3,325

Consensus EPS estimates fall by 15%

Consensus EPS estimates fall by 12%

Price target decreased to ₹3,582

Price target decreased to ₹3,685

Recent updates

Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Divi's Laboratories Limited Approves Appointment of Dr. S. Devendra Rao as Whole-Time Director (Manufacturing)

Insider recently sold ₹24m worth of stock

Chief Technologist recently sold ₹56m worth of stock

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q3, 2024 Results on Feb 10, 2024

Insider recently sold ₹59m worth of stock

Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Non-Executive Independent Director recently sold ₹1.4m worth of stock

Consensus EPS estimates fall by 10%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q2, 2024 Results on Nov 06, 2023

Insider recently sold ₹3.3m worth of stock

Chief Technologist recently sold ₹2.9m worth of stock

Divi's Laboratories Limited Declares Dividend for the Financial Year Ended March 31, 2023

Divi's Laboratories Limited Informs Resignations of Directors

Price target increased by 7.3% to ₹3,325

New minor risk - Profit margin trend

Insufficient new directors

Divi's Laboratories Limited to Report Q1, 2024 Results on Aug 14, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ₹30.00 per share at 0.8% yield

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

New minor risk - Insider selling

Divi's Laboratories (NSE:DIVISLAB) Has Announced A Dividend Of ₹30.00

Divi's Laboratories Limited, Annual General Meeting, Aug 28, 2023

Insider recently sold ₹3.4m worth of stock

Divi's Laboratories Limited Recommends a Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹68.69 (vs ₹112 in FY 2022)

Divi's Laboratories Limited to Report Q4, 2023 Results on May 20, 2023

Insider recently sold ₹2.0m worth of stock

Global Quality Head recently sold ₹2.3m worth of stock

Global Quality Head recently sold ₹2.8m worth of stock

Global Quality Head recently sold ₹28m worth of stock

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 15%

Divi's Laboratories Limited to Report Q3, 2023 Results on Feb 03, 2023

Board Member recently sold ₹10m worth of stock

MD & Executive Director recently sold ₹1.0m worth of stock

Insider recently sold ₹1.7m worth of stock

Insider recently sold ₹1.2m worth of stock

Consensus EPS estimates fall by 12%

Price target decreased to ₹3,582

Price target decreased to ₹3,685

Price target decreased to ₹3,685

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Insider recently sold ₹1.5m worth of stock

Insider recently sold ₹3.7m worth of stock

Upcoming dividend of ₹30.00 per share

Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00

Divi's Laboratories Limited to Report Q1, 2023 Results on Aug 12, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Divi's Laboratories Limited Recommends Dividend

Divi's Laboratories Limited, Annual General Meeting, Aug 22, 2022

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Insider recently sold ₹2.5m worth of stock

Insider recently sold ₹7.3m worth of stock

Divi's Laboratories Limited Recommends A Dividend for the Year 2021-2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Divi's Laboratories Limited to Report Q4, 2022 Results on May 23, 2022

Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Insider recently sold ₹2.7m worth of stock

Board Member recently sold ₹21m worth of stock

Insider recently bought ₹796k worth of stock

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations